Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Dexter

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|January 20, 1993
Effects of modulation of basic fibroblast growth factor on tumor growth in vivoJ L Gross, W F Herblin, B A Dusak, et al.
Cancer Research|December 1, 1983
"COLO 357," a human pancreatic adenosquamous carcinoma: growth in artificial capillary culture and in nude miceP A Meitner, S M Kajiji, N LaPosta-Frazier, et al.
Journal of the National Cancer Institute|November 1, 1983
Nude mouse model of the melanosis syndromeE N Spremulli, H A Bogaars, D L Dexter, et al.
Cancer Research|March 1, 1981
N,N-dimethylformamide and sodium butyrate modulation of the activities of purine-metabolizing enzymes in cultured human colon carcinoma cellsD L Dexter, G W Crabtree, J D Stoeckler, et al.
Biochemical Pharmacology|April 1, 1981
Activities of purine-metabolizing enzymes in human colon carcinoma cell lines and xenograft tumorsG W Crabtree, D L Dexter, J D Stoeckler, et al.
Cancer Research|January 15, 1997
Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin SJ R MacDonald, C C Muscoplat, D L Dexter, et al.
Cancer Research|April 15, 1990
Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell lineR S Morrison, J L Gross, W F Herblin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancersP J Houghton, P J Cheshire, J C Hallman, et al.
Biochemical Pharmacology|July 15, 1982
Biochemical pharmacology and toxicology of 8-azaadenosine alone and in combination with 2'-deoxycoformycin (pentostatin)E N Spremulli, G W Crabtree, D L Dexter, et al.
Cancer Treatment Reports|March 1, 1983
Biochemical pharmacology and toxicology of formycin alone and in combination with 2'-deoxycoformycin (pentostatin)E N Spremulli, G W Crabtree, D L Dexter, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|January 20, 1993
Effects of modulation of basic fibroblast growth factor on tumor growth in vivoJ L Gross, W F Herblin, B A Dusak, et al.
Cancer Research|December 1, 1983
"COLO 357," a human pancreatic adenosquamous carcinoma: growth in artificial capillary culture and in nude miceP A Meitner, S M Kajiji, N LaPosta-Frazier, et al.
Journal of the National Cancer Institute|November 1, 1983
Nude mouse model of the melanosis syndromeE N Spremulli, H A Bogaars, D L Dexter, et al.
Cancer Research|March 1, 1981
N,N-dimethylformamide and sodium butyrate modulation of the activities of purine-metabolizing enzymes in cultured human colon carcinoma cellsD L Dexter, G W Crabtree, J D Stoeckler, et al.
Biochemical Pharmacology|April 1, 1981
Activities of purine-metabolizing enzymes in human colon carcinoma cell lines and xenograft tumorsG W Crabtree, D L Dexter, J D Stoeckler, et al.
Cancer Research|January 15, 1997
Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin SJ R MacDonald, C C Muscoplat, D L Dexter, et al.
Cancer Research|April 15, 1990
Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell lineR S Morrison, J L Gross, W F Herblin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Evaluation of a novel bis-naphthalimide anticancer agent, DMP 840, against human xenografts derived from adult, juvenile, and pediatric cancersP J Houghton, P J Cheshire, J C Hallman, et al.
Biochemical Pharmacology|July 15, 1982
Biochemical pharmacology and toxicology of 8-azaadenosine alone and in combination with 2'-deoxycoformycin (pentostatin)E N Spremulli, G W Crabtree, D L Dexter, et al.
Cancer Treatment Reports|March 1, 1983
Biochemical pharmacology and toxicology of formycin alone and in combination with 2'-deoxycoformycin (pentostatin)E N Spremulli, G W Crabtree, D L Dexter, et al.
Pageof 8